speb/financial-data huggingface dataset:
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -180476000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -91362000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 22557000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Change In Payable: 42859000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -39381000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -287762000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 169541000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Common Stock: 126511000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 1934141000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 334116000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 0.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 859915000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Current Assets: 1633627000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Current Debt: 248394000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 248394000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 36996000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 825735000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 6903000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Deferred Tax: 23165000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Depreciation: 62563000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 63666000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 63666000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 62563000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 12651100.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Diluted EPS: 11.73
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 148441000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 1004000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — EBIT: 199677000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — EBITDA: 263343000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — End Cash Position: 207788000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 291273000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 170457000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -128939000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -68000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 43818000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 8977000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 1288557000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Gross Profit: 548759000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Interest Expense: 29227000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 29227000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Interest Income: 7207000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 7207000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -29227000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 7207000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Inventory: 450573000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 2191231000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -58804000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 0.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 334116000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 40381000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 9424000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 8696000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 8696000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -42040000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 16601000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 733945000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 1206000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Minority Interests: 1156000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 334116000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Net Debt: 49301000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Net Income: 148441000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 148441000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 147285000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 148441000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 148441000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 147285000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 147285000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Net Interest Income: -26712000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 0.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -1659000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -42040000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -26712000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 4834000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Net PPE: 917588000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -66011000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 40381000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 1925164000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 18795000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 16601000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 11066000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 272325000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Normalized Income: 156202301.67
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -62928000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Operating Income: 188895000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Operating Revenue: 1408674000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 12651100.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: -1000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 39825000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 26055000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 8977000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 86623000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 22020000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 195120000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 2490000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 2967000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Other Payable: 39604000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Other Properties: 173309000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 25147000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Other Special Charges: -99000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Payables: 472304000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 6903000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 97384000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Pretax Income: 170450000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: 0.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -66011000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 184502000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 859915000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 63666000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 3976000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 3976000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -42040000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 3109000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 825383000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 38929000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 82747000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Share Issued: 12651100.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 40381000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Special Income Charges: -8982000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 1934141000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 1925164000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -1220698.33
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Tax Provision: 23165000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.14
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 197045000.00
MEDICAMEQ.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -31234000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Total Assets: 2785173000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 1942837000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Total Debt: 257090000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 1934141000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Total Expenses: 1219779000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 851032000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 1151546000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 25297000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 4692000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 36996000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -8982000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -8982000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 16601000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Work In Process: 8991000.00
MEDICAMEQ.NS balance_sheet (annual, 2023-03-31) — Working Capital: 807892000.00
MEDICAMEQ.NS income_statement (annual, 2023-03-31) — Write Off: 9081000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — +Operating Expense: 523536000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — +Total Revenue: 1793062000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 389488000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 552593000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -440050000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 1023117000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Amortization: 1744000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 1744000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 12659277.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Basic EPS: 8.63
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 207788000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 373192000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -62872000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 127146000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 147856000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 147856000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -12651000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 139202000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 8654000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -143179000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -171339000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 37747000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Change In Payable: -86371000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 123188000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -275209000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -59932000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Common Stock: 127146000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 2050929000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 18966000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 0.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 1095484000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Current Assets: 1595937000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Current Debt: 298560000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 298560000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 40628000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 845554000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 9228000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Deferred Tax: 35816000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Depreciation: 69188000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 70932000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 70932000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 69188000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 12659277.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Diluted EPS: 8.63
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 109310000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 1114000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — EBIT: 174728000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — EBITDA: 245660000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — End Cash Position: 147856000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 63135000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 186900000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -130310000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 3000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 66777000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 8983000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 1349568000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Gross Profit: 697578000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Interest Expense: 43972000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 43972000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Interest Income: 7243000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 7243000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -43972000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 7243000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Inventory: 593752000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 2362044000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -55629000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 0.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 18966000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 62486000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 9424000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 12555000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 12555000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 3859000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 17558000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 774216000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 18915000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Minority Interests: 14370000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 18966000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Net Debt: 163259000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Net Income: 109310000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 109310000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 94940000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 109310000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 109310000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 94940000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 94940000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Net Interest Income: -49475000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 0.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 66345000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 3859000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -49475000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 34447000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -4000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Net PPE: 909518000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -62872000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 62486000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 2041946000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 25148000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 12191000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 254752000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Normalized Income: 115911566.89
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: -67438000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Operating Income: 174042000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Operating Revenue: 1793062000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 12714600.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 256802000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 81527000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 1877711000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 8983000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 85439000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 36729000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 393733000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: -1000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 1427000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 4107000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Other Payable: 25009000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Other Properties: 192736000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 21807000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Other Special Charges: -736000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Payables: 415611000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 9228000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 71346000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Pretax Income: 130756000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: 0.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -62872000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 159455000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 1095484000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 70932000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 4133000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 4133000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 4238000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 907673000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 75823000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 142600000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Share Issued: 12714600.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 62486000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Special Income Charges: -9092000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 2050929000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 2041946000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -2490433.11
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Tax Provision: 35816000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.27
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 204345000.00
MEDICAMEQ.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -30650000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Total Assets: 2945510000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 2063484000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Total Debt: 311115000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 2069844000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Total Expenses: 1619020000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 875666000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 1349573000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 30112000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 12746000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 0.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -9092000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -9092000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Tradeand Other Payables Non Current: 17558000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Work In Process: 161958000.00
MEDICAMEQ.NS balance_sheet (annual, 2024-03-31) — Working Capital: 750383000.00
MEDICAMEQ.NS income_statement (annual, 2024-03-31) — Write Off: 9828000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 448960000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 566444000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 12714600.00
MEDICAMEQ.NS income_statement (quarterly, 2024-09-30) — Basic EPS: 0.71
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 127146000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 64150000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 64150000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 127146000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 2159148000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 0.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 1567685000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 187685000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 187685000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 687969000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 3987000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 12714600.00
MEDICAMEQ.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.71
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 9234000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 877955000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 599697000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 2360831000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 0.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 13998000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 13998000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 23940000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-09-30) — Minority Interests: 5525000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 137533000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 877955000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 2149914000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 24922000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 60000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 12714600.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 294961000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 6708000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 2032002000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 393299000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: -1000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 877955000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 42433000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Payables: 489589000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 12714600.00
MEDICAMEQ.NS income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 2159148000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 2149914000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 2885114000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 2173146000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 201683000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 2159148000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 725966000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 1317429000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 37997000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 40629000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
MEDICAMEQ.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 879716000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 183258000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 451422000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 12704348.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 2.30
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 223207000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 22097000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 22097000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 12704348.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 2.30
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 29220000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — EBIT: 46365000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — EBITDA: 68462000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 228215000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 7595000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 7595000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Net Income: 29220000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 29220000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 29220000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 29220000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 29220000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 29220000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -7595000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -7595000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 68462000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 29220000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Operating Income: 44957000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 451422000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 1407000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 81112000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 38770000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 223207000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 22097000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 9550000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.25
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 406465000.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
MEDICAMEQ.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — +Operating Expense: 711370000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 179355000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — +Total Revenue: 1625472000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 296129000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 426517000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 426517000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 688997000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 688997000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -506677000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -506677000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 1023117000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1023117000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Amortization: 1560000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 12714600.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 16436735.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Basic EPS: 5.16
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 1.47
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 147856000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 374911000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 374911000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -21885000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 127146000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 127146000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 37594000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 37594000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 37594000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 37594000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -12715000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 29493000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 29493000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 8101000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 8101000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -27622000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -11320000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -95911000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Change In Payable: 37029000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -128120000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -262476000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -110262000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Common Stock: 127146000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 127146000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 2118551000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 2118551000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 0.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 0.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 846180000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 137646000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Current Assets: 1645493000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 1645493000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Current Debt: 300399000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 300399000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 300399000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 300399000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 33243000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 33243000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 781618000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 781618000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 8135000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 8135000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Deferred Tax: 33243000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Depreciation: 69101000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 69101000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 70661000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 4789000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 70661000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 4789000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 12714600.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 16436735.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Diluted EPS: 5.16
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.47
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 71082000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 24162000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 1338000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 1338000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — EBIT: 130361000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — EBIT: 31402000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — EBITDA: 201022000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — EBITDA: 36191000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — End Cash Position: 37594000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -14706000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 311078000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 311078000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -103473000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 69247000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 7423000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 7423000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 1370299000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1370299000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Gross Profit: 779292000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 158483000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Interest Expense: 31561000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 6499000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 31561000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 6499000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Interest Income: 5073000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 5073000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -31561000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 5073000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Inventory: 621374000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 621374000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 2456293000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2456293000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -13968000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 0.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 24788000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 9424000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 9424000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 37343000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 37343000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 37343000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 37343000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 24788000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 0.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 22044000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 22044000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 789862000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 789862000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 11979000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 11979000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Minority Interests: 5525000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 5525000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 0.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Net Debt: 300148000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 300148000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Net Income: 71082000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Net Income: 24162000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 71082000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 24162000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 65557000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 18637000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 71082000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 24162000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 71082000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 24162000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 65557000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 65557000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 18637000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Net Interest Income: -31561000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -6499000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 0.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 24358000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 24788000.00
MEDICAMEQ.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -31561000.00
MEDICAMEQ.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -6499000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 5212000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 2844000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Net PPE: 863622000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 863622000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -21885000.00
MEDICAMEQ.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -430000.00
MEDICAMEQ.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 2111128000.00
MEDICAMEQ.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2111128000.00